Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Adynxx Inc. (ADYX)

0.41   0.005 (1.23%) 06-01 10:22
Open: 0.41 Pre. Close: 0.405
High: 0.41 Low: 0.41
Volume: 455 Market Cap: 2M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.41 - 0.413 0.413 - 0.415
Low: 0.404 - 0.408 0.408 - 0.41
Close: 0.406 - 0.411 0.411 - 0.414

Technical analysis

as of: 2020-06-01 12:54:53 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.58     One year: 0.68
Support: Support1: 0.37    Support2: 0.31
Resistance: Resistance1: 0.50    Resistance2: 0.58
Pivot: 0.42
Moving Average: MA(5): 0.41     MA(20): 0.42
MA(100): 0.82     MA(250): 1.48
MACD: MACD(12,26): -0.02     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 5.56     %D(3): 5.25
RSI: RSI(14): 46.00
52-week: High: 6.07  Low: 0.31  Change(%): -92.2
Average Vol(K): 3-Month: 152  10-Days: 65

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ADYX has closed above bottom band by 43.8%. Bollinger Bands are 80.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ADYX's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 14 Nov 2019
Adynxx Reports Third Quarter 2019 Financial Results Other OTC:ADYX - GlobeNewswire

Fri, 10 May 2019
Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical - GlobeNewswire

Mon, 06 May 2019
Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors - GlobeNewswire

Mon, 22 Jul 2019
Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB Market - GlobeNewswire

Wed, 12 Jun 2019
Adynxx Stock to Move to OTC Market Following Receipt of Nasdaq Delisting Notice - GlobeNewswire

Mon, 22 Apr 2019
Adynxx Announces Merger Agreement with Alliqua BioMedical and Provides Business and Clinical Update - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 6
Shares Float (M)
% Held by Insiders 10.45
% Held by Institutions 71.81
Shares Short (K) 26
Shares Short P. Month (K) 18

Stock Financials

EPS -1.819
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -1.900
Profit Margin
Operating Margin
Return on Assets (ttm) -192.3
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.355
Qtrly Earnings Growth
Operating Cash Flow (M) -6
Levered Free Cash Flow (M) -6

Stock Valuations

PE Ratio -0.23
PEG Ratio
Price to Book value -0.22
Price to Sales
Price to Cash Flow -0.39

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2019-05-28
Ex-Dividend Date 2019-05-05
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.